Category: Drug Discovery
Drug Discovery market research reports by GlobalData
-
Innovation Insights: AI for drug target identification
Innovation Insights: AI for drug target identification Summary Artificial Intelligence (AI) is revolutionizing drug target identification by leveraging vast datasets and advanced algorithms to uncover novel therapeutic targets. AI techniques, such as machine learning and natural language processing, ... Read More
-
Innovation Insights: RNA-targeting Small Molecules
Innovation Insights: RNA-targeting Small Molecules Summary The state of innovation in RNA targeting small molecules, a class of drugs that can bind to RNA structures and alter translation patterns, localization, and degradation. The analysis reveals that this is a relatively new innovation area comp ... Read More
-
Innovation Insights: Targeted Delivery of Oligos to Kidney/Heart
Innovation Insights: Targeted Delivery of Oligos to Kidney/Heart Summary Targeted Delivery of Oligonucleotides explores the innovative strategies and technologies used to deliver oligonucleotides to specific cells or tissues in the body. Oligonucleotides are short DNA or RNA molecules that have the ... Read More
-
Progressive Supranuclear Palsy: Competitive Landscape
Progressive Supranuclear Palsy: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Progressive Supranuclear Palsy therapeutics. GlobalData epidemiologists estimate that there will be 263,657 diagnosed prevalent cases of PSP i ... Read More
-
Alzheimer’s Disease: Eight-Market Drug Forecast and Market Analysis
Alzheimer’s Disease: Eight-Market Drug Forecast and Market Analysis Summary This report covers the 8 major markets and provides an Excel-based forecast model for the Alzheimer’s Disease market through 2033. GlobalData estimates that the value of the Alzheimer’s Disease (AD) market in the 8MM in 2023 ... Read More
-
Hepatitis C Therapeutics: Competitive Landscape
Hepatitis C Therapeutics: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hepatitis C Therapeutics . GlobalData epidemiologists estimate that there will be 25.16 million diagnosed prevalent cases of Hepatitis C (HCV) infec ... Read More
-
Pharmaceutical Review Designations: Trends and Industry Insights
Pharmaceutical Review Designations: Trends and Industry Insights Summary This report investigates review designations in the pharmaceutical industry from the standpoint of drug development. It provides an in- depth review of the history and available designations alongside high-level analysis of key ... Read More
-
Drug Development Trends in China
Drug Development Trends in China Summary China has emerged as a critical player in global drug development, driven by robust innovation. The pharmaceutical industry in China has seen a surge in drug development activities in recent years, with an increasing focus on innovative therapies such as CAR- ... Read More
-
Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countri ... Read More
-
Hepatitis B Therapeutics: Competitive Landscape
Hepatitis B Therapeutics: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hepatitis B Therapeutics . GlobalData epidemiologists estimate that there will be 21.91 million diagnosed prevalent cases of HBV in 2024, which is e ... Read More
-
Strategic Intelligence: AI in drug discovery
Strategic Intelligence: AI in drug discovery Summary In recent years, the pharma industry has been taken over by a wave of digital transformation, leading to the integration of advanced technologies across different aspects of the pharma value chain. Artificial intelligence (AI) and big data are at ... Read More
-
Glomerulonephritis: Competitive Landscape
Glomerulonephritis: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Glomerulonephritis therapeutics. GlobalData epidemiologists estimate that there will be 51,900 diagnosed incident cases of ANCA-associated GMN in 2024, wh ... Read More
-
Metabolic Dysfunction-Associated Steatohepatitis (MASH) - Global Clinical Trials Review, 2024
Metabolic Dysfunction-Associated Steatohepatitis (MASH) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Metabolic Dysfunction-Associated Steatohepatitis (MASH) - Global Clinical Trials Review, 2024 provides an overview of Metabolic Dysfunction-Associated Steatohepa ... Read More
-
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Global Clinical Trials Review, 2024
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Global Clinical Trials Review, 2024 provides an overview of Metabolic Dysfunction-Ass ... Read More
-
Epidermolysis Bullosa: Competitive Landscape
Epidermolysis Bullosa: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Epidermolysis Bullosa therapeutics. GlobalData epidemiologists estimate that there will be 21,154 diagnosed prevalent cases of EB in 2024, which is exp ... Read More
-
Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review
Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Esophageal Cancer: Competitive Landscape
Esophageal Cancer: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Esophageal Cancer therapeutics. In 2024, more than 410,000 diagnosed incident cases of EC are anticipated in the 16 countries covered in GlobalData’s epide ... Read More
-
Sepsis: Epidemiology Forecast to 2033
Sepsis: Epidemiology Forecast to 2033 Summary Sepsis is a life-threatening complication arising from an infection, which occurs when the body’s response to the infection damages its own tissues and organs. Sepsis causes multiple organ failure and death, especially if it is not recognized early and t ... Read More
-
Limb-Girdle Muscular Dystrophy (LGMD): Competitive Landscape
Limb-Girdle Muscular Dystrophy (LGMD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Limb-Girdle Muscular Dystrophy therapeutics. In 2024, more than 111,000 diagnosed prevalent cases of LGMD are anticipated in the 16 cou ... Read More
-
Gonorrhea (GN): Competitive Landscape
Gonorrhea (GN): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Gonorrhea therapeutics. In 2024, more than 3.7 million diagnosed incident cases of GN are anticipated in the 16 countries covered in GlobalData’s epidemiology ... Read More
-
Multiple System Atrophy (MSA): Competitive Landscape
Multiple System Atrophy (MSA): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Multiple System Atrophy therapeutics. In 2024, more than 226,000 diagnosed prevalent cases of MSA are anticipated in the 16 countries covered i ... Read More
-
Glycogen Storage Disorders (GSD): Competitive Landscape
Glycogen Storage Disorders (GSD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Glycogen Storage Disorders therapeutics. In 2024, more than 2,000 diagnosed incident cases of GSD are anticipated in the 16 countries covere ... Read More
-
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region ... Read More
-
Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Devel ... Read More
-
Biosensors in Europe
Biosensors in Europe Summary Biosensors in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key fin ... Read More
Research Assistance
